Mack Su is a Dermatology physician affiliated with Boston Medical Center. OpenAlex indexes 33 publications with 2,386 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
53.8%Azole Antifungal43.7%Ketoconazole100%Part D≥25 patientsNitroimidazole Antimicrobial10.1%Metronidazole100%Part D<11 patientsDermatology
14.3%Corticosteroid14.3%Triamcinolone Acetonide100%Part D≥13 patientsRespiratory
12.6%RNA Synthetase Inhibitor Antibacterial12.6%Mupirocin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2018–2019 per NIH RePORTER. The latest:
- The role of UV-induced neoantigens and exogenous neoepitopes in enhancing response to immune checkpoint blockade in melanoma and other cancers.
Harvard Medical School
FY2019$50,016F30ES028995 - The role of UV-induced neoantigens and exogenous neoepitopes in enhancing response to immune checkpoint blockade in melanoma and other cancers.
Harvard Medical School
FY2018$38,243F30ES028995
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 64307 Switching between Janus kinase inhibitors for treatment of alopecia areata
Journal of the American Academy of Dermatology
2025 - 64345 Systemic Janus kinase inhibitors in the treatment of lichen planopilaris: A retrospective review
Journal of the American Academy of Dermatology
2025 - Shape Public Perceptions: Multimodal Analysis of COVID-19 Vaccine Narratives in Chinese Posters
The Journal of Medicine Humanity and Media
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Alice Jacobs, MD
Boston Medical Center
Carlos Kase, MD
Boston Medical Center
Sushrut Waikar, MD
Boston Medical Center
Geoffrey Oxnard, MD
Boston Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”